Performance status of health care facilities changes with risk adjustment of HbA(1c)

Diabetes Care

Volumn 23, Issue 7, 2000, Pages 919-927

  Zhang, Quanwu ^a,b,h   Safford, Monika ^a,b   Ottenweller, John ^a,b   Hawley, Gerald ^c,d   Repke, Denis ^d   Burgess Jr , James F ^e,f   Dhar, Sunil ^c   Cheng, Hsiaofen ^c,i   Natto, Herbert ^g   Pogach, Leonard M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^d CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Vet Aff Management Science Group   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^h MERCK RESEARCH LABORATORIES   (United States)

ⁱ DoubleClick Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; COMORBIDITY; CORONARY RISK; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HOSPITALIZATION; OUTPATIENT; PATIENT CARE; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 0033942008     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.7.919     Document Type: Article

References (50)

1. Herman WH, Eastman RC: The effects of treatment on the direct costs of diabetes. Diabetes Care 21 (Suppl. 3):C19-C24, 1998
2. U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
3. Clark CM, Lee DA: Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 332:1210-1217, 1995
4. Testa MA, Simonson DC: Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. JAMA 280:1490-1496, 1998
5. Diabetes Quality Improvement Project Initial Measure Set (Final Version): 14 August 1998. http://www.diabetes.org/
6. Donabedian A: Basic approaches to assessment: structure, process, and outcome. In The Definition of Quality and Approaches to Its Assessment. Ann Arbor, MI, Health Administration Press, 1980, p. 77-128
7. Palmer RH: Quality of care. JAMA 277: 1896-1897, 1997
8. Chassin MR, Galvin RW, the National Roundtable on Health Care Quality: The urgent need to improve health care quality. JAMA 280:1000-1005, 1998
9. Mitka M: Renewed efforts to improve the quality of health care. JAMA 281:404, 1999
10. Pogach LM, Hawley G, Weinstock R, Sawin C, Schiebe H, Cutler F, Zieve F, Bates M, Repke D: Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994): use of an ambulatory care pharmacy-derived database. Diabetes Care 21:368-373, 1998
11. Naito H, Hartfiel J, Little R, Pogach L: Standardization of glycohemoglobin (GHB) methods in the Department of Veterans Affairs Medical Centers. American Diabetes Association Annual Meeting, San Francisco, CA, June 1996
12. Naito H, Hartfiel J, Eckfeldt J, Pogach L: Matrix-induced biases observed with proficiency testing survey materials that are used for glycohemoglobin testing. American Diabetes Association Annual Meeting, San Francisco, CA, June 1996
13. Chassin MR, Hannan EL, DeBuono BA: Benefits and hazards of reporting medical outcomes publicly. N Engl J Med 334:394-398, 1996
14. Harris MI, Eastman R, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22:403-408, 1999
15. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Weidmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose tolerance in US adults: the Third National Health and Nutritional Examination Survey, 1988-1994. Diabetes Care 21:518-524, 1998
16. Weiner JP, Parente ST, Garnick DW, Fowles J, Lawthers AG, Palmer H: Variation in office-based quality: a claims-based profile of care provided to Medicare patients with diabetes. JAMA 273:1503-1508, 1995
17. Brook RH, Kamberg CJ, McGlynn EA: Health system reform and quality. JAMA 276:476-480, 1996
18. Keeler EB, Rubenstein LV, Kahn KL, Draper D. Harrison ER, McGinty MJ, Rogers WH, Brook RH: Hospital characteristics and quality of care. JAMA 268:1709-1714, 1992
19. Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin-dependent diabetes. In Diabetes in America, 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 47-67 (NIH publ. no. 95-1468)
20. Charlson ME, Pompei R, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383, 1987
21. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
22. Bryk AS, Raudenbush SW: Hierarchical Linear Models: Applications and Data Analysis Methods. Newbury Park, CA, Sage Publications, 1992
23. Longford NT: Random Coefficient Models. New York, Oxford University Press, 1993
24. Hu FB, Goldberg J, Hedeker D, Henderson WG: Modelling ordinal responses from cotwin control studies. Stat Med 17:957-970, 1998
25. Akaike H: A new look at the statistical model identification. IEEE Trans Autom Control 19:716-723, 1974
26. McBean AM, Hebert P, Engelgau M, Geiss L, Tierney E: National Diabetes Cohort, Tampa, FL, Centers for Disease Control and Prevention Translation Conference, 1998
27. American Diabetes Association: Economic Consequences of Diabetes Mellitus in the U.S. in 1997. Alexandria, VA, American Diabetes Association, 1998, p. 296-309
28. Selby JV, Ray GT, Zhang D, Coby CJ: Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20:1396-1402, 1997
29. Javitt JC, Chiang Y: Economic impact of diabetes. In Diabetes in America, 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 601-612 (NIH publ. no. 95-1468)
30. Eastman R, Javitt JC, Herman W, Dasbach EJ, Zbrozek AS, Dong F, Manninen D, Garfield SA, Copley-Merriman C, Maier W, Eastman JF, Kotsanos J, Cowie CC, Harris M: Model of complications of NIDDM: model construction and assumptions. Diabetes Care 20:725-734, 1997
31. Harris MI, Eastman RG, Siebert C: The DCCT and medical care for diabetes in the U.S. Diabetes Care 17:761-764, 1994
32. Fertig BJ, Simmons DA, Martin DB: Therapy for diabetes. In Diabetes in America, 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 519-540 (NIH publ. no. 95-1468)
33. DCCT Group: Lifetime benefits and costs of intensive therapy as practices in the Diabetes Control and Complications Trial. JAMA 276:1409-1415, 1996
34. U.K. Prospective Diabetes Study 34: Effect of intensive blood-glucose control with metformin on complication in overweight patients with type 2 diabetes. Lancet 352: 854-865, 1998
35. U.K. Prospective Diabetes Study 40: Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes. BMJ 317:720-726, 1998
36. Brinkley J: U.S. releasing lists of hospitals with abnormal mortality rates. New York Times. 12 March 1986: Sect. A, p. 1
37. Daley J, Jencks S, Draper D, Lenhart G, Thomas N, Walker J: Predicting hospital-associated mortality for Medicare patients: a method for patients with stroke, pneumonia, acute myocardial infarction and congestive heart failure. JAMA 260:3617-3624, 1988
38. Iezzoni LI, Shwartz M, Ash AS, Hughes JS, Kaley J, Mackiernan YD: Using severity-adjusted stroke mortality rates to judge hospitals. Int J Qual Health Care 7:81-94, 1995
39. Hannan EL, Siu AL, Kumar D, Kilburn H Jr., Chassin MR: The decline in coronary artery bypass graft surgery mortality in New York State: the role of surgeon volume. JAMA 273 209-213, 1995
40. Jollis JG, Romano PS: Pennsylvania's focus on heart attack: grading the score card. N Engl J Med 338:983-987, 1998
41. Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, Manning WG: The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA 281:2098-2105, 1999
42. Tull ES, Roseman JM: Diabetes in African Americans. In Diabetes in America, 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC. U.S. Govt. Printing Office, 1995, p. 613-630 (NIH publ. no. 95-1468)
43. Haffner SM, Hazuda HP, Stern MP, Patterson JK, Van Heuven WAJ, Fong D: Effect of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM. Diabetes Care 12:128-134, 1989
44. Blaum CS, Velez L, Hiss RG, Halter JB: Characteristics related to poor glycemic control in NIDDM patients in community practice. Diabetes Care 20:7-11, 1997
45. Eberhardt MS, Lackland DT, Wheeler FC, German RR, Teuttsch SM: Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities. J Clin Epidemiol 47:1181-1189, 1994
46. Iezzoni LI: Risk and outcomes. In Risk Adjustment for Measuring Healthcare Outcomes. Iezzoni LI, Ed. Chicago, Health Administration Press, 1997, p. 1-42
47. Von Korff M, Wagner EH, Saunders K: A chronic disease score from automated pharmacy data. J Clin Epidemiol 45:197-203, 1992
48. Krop JS, Powe NR, Weller WE, Shaffer TJ, Saudek CD, Anderson GF: Patterns of expenditures and use of services among older adults with diabetes: implications for the transition to capitated managed care. Diabetes Care 21:747-752, 1998
49. Medicare Most beneficiaries with diabetes do not receive recommended monitoring services. General Accounting Office, Department of Health and Human Services, Report 97-48, 28 March 1997
50. Fleming C, Fisher ES, Chang CH, Bubolz TA, Malenka DJ: Studying outcomes and hospital utilization in the elderly: the advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care 30:377-391, 1992